Related Experiment Videos
Multidrug resistance in cancer
Scientific American
|March 1, 1989
Abstract:
Chemotherapy often fails because a tumor develops resistance to an array of different drugs. A single glycoprotein turns out to be responsible: it proliferates in some cells and pumps out the drugs. Now that the protein pump has been identified it may be possible to interfere with its action or to make it the target for drugs that destroy the cancer cell.
Insights
A specific glycoprotein causes chemotherapy drug resistance by pumping drugs out of cancer cells. Identifying this protein pump offers new therapeutic targets for overcoming treatment failure.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Chemotherapy resistance is a major challenge in cancer treatment.
- Tumor cells can develop resistance to multiple drugs, leading to treatment failure.
Purpose of the Study:
- To identify the specific molecular mechanism responsible for multidrug resistance in cancer.
- To explore potential therapeutic strategies targeting this mechanism.
Main Methods:
- Analysis of protein expression in resistant cancer cells.
- Biochemical assays to determine protein function.
Main Results:
- A single glycoprotein was identified as the key factor in drug efflux.
- This glycoprotein proliferates in resistant cancer cells, actively pumping out chemotherapeutic agents.
Conclusions:
- The identified glycoprotein acts as a drug pump, mediating chemotherapy resistance.
- Targeting this specific glycoprotein presents a promising strategy for overcoming multidrug resistance and improving cancer therapy outcomes.